돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 43522생성일: 2026년 10월 23일

2-Methyl-2-butene → cis(+/-)-2-(4-{[(4-Chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}-3-ethoxypiperidin-1-yl)-5-(ethoxycarbonyl)-1,3-thiazole-4-carboxylic acid

https://huagongshe.com/ko/reaction/43522

반응식

참여 물질

역할이름HCID투입량
반응물2-Methyl-2-buteneHCID 10553—
반응물Sodium ChloriteHCID 23668197—
반응물Monosodium phosphateHCID 23672064—
반응물ethyl cis(+/-)-2-(4-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}-3-ethoxypiperidin-1-yl)-4-formyl-1,3-thiazole-5-carboxylateHCID 86648530—
생성물cis(+/-)-2-(4-{[(4-Chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}-3-ethoxypiperidin-1-yl)-5-(ethoxycarbonyl)-1,3-thiazole-4-carboxylic acidHCID 8664852999.3%

반응 단계

The same operation as in Example (33c) was performed using ethyl cis(±)-2-(4-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}-3-ethoxypiperidin-1-yl)-4-formyl-1,3-thiazole-5-carboxylate obtained in Example (68b) (about 0.63 mmol), sodium chlorite (113 mg, 1.25 mmol), sodium dihydrogenphosphate (320 mg, 2.05 mmol) and 2-methyl-2-butene (0.33 mL, 3.12 mmol), to obtain 312.7 mg of the title compound as a white solid (99%).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08536197B2
출처 데이터셋uspto-grants-2013_09
ORD IDord-6c6ef6ad472142c4bf230d3791b6bc15
출처 메모uspto-grants-2013_09